Paediatric Covaxin: Bharat Biotech completes phase 2/3 trials ...Middle East

Devdiscourse - Opinion
Paediatric Covaxin: Bharat Biotech completes phase 2/3 trials
Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the DCGI, Chairman and Managing Director of Bharat Biotech International Ltd, Krishna Ella said on Tuesday here.

Hence then, the article about paediatric covaxin bharat biotech completes phase 2 3 trials was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Paediatric Covaxin: Bharat Biotech completes phase 2/3 trials )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Opinion


Latest News